Targeting mature T cell leukemia: New understanding of molecular pathways

American Journal of PharmacoGenomics

Volumn 3, Issue 1, 2003, Pages 31-36

  Pekarsky, Yuri ^a   Hallas, Cora ^a   Croce, Carlo M ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN KINASE B; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR;

APOPTOSIS; CHROMOSOME 14Q; CHROMOSOME ABERRATION; CHROMOSOME INVERSION; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION; CHRONIC LYMPHATIC LEUKEMIA; ENZYME PHOSPHORYLATION; GENE ACTIVATION; GENE EXPRESSION; GENE LOCUS; GENE OVEREXPRESSION; HEMATOLOGIC MALIGNANCY; LEUKEMOGENESIS; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROLYMPHOCYTIC LEUKEMIA; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN TRANSPORT; REVIEW; SIGNAL TRANSDUCTION; T CELL LEUKEMIA; T CELL LYMPHOMA; T LYMPHOCYTE; THYMOCYTE; TRANSGENIC MOUSE;

ANIMALS; DRUG DELIVERY SYSTEMS; HUMANS; LEUKEMIA, T-CELL; SIGNAL TRANSDUCTION;

MUS MUSCULUS;

EID: 0037219339     PISSN: 11752203     EISSN: None     Source Type: Journal    
DOI: 10.2165/00129785-200303010-00005     Document Type: Review

References (55)

1. Kingreen D, Siegert W. Chronic lymphatic leukemias of T and NK cell type. Leukemia 2000; 11: s46-9
2. Catofsky D. Chronic lymphoproliferative disorders. Curr Opin Oncol 1995; 7: 3-11
3. Matutes E, Brito-Babapulle V, Swansbury J, et al. Clinic and laboratory features of 78 cases of T-prolymphocytic leukemia. Blood 1991; 78: 3269-73
4. Pugh WC, McBride JA. The pathologic basis for the classification of non-Hodgkin lymphomas. In: Hoffman R, editor Hematology: basic principles and practice. 3rd ed. New York: Churchill-Livingstone, 2000: 1263-93
5. Brito-Babapulle V, Catovsky D. Inversions and tandem translocations involving chromosome 14q11 and 14q32 in T-prolymphocytic leukemia and T-cell leukemias in patients with ataxia telangiectasia. Cancer Genet Cytogenet 1991; 55: 1-9
6. Croce CM. Role of chromosome translocations in human neoplasia. Cell 1987; 49: 155-6
7. Rabbitts TH. Translocations, master genes, and differences between the origins of acute and chronic leukemias. Cell 1991; 67: 641-3
8. Croce CM, Isobe M, Palumbo A, et al. Gene for alpha-chain of human T-cell receptor: location on chromosome 14 region involved in T-cell neoplasms. Science 1985; 227: 1044-77
9. Erikson J, Finan JB, Nowell PC, et al. Translocation of immunoglobulin VH genes in Burkitt lymphoma. Proc Natl Acad Sci U S A 1982; 79: 5611-5
10. ar-Rushdi A, Nishikura K, Erikson J, et al. Differential expression of the translocated and the untranslocated c-myc oncogene in Burkitt lymphoma. Science 1983; 222: 390-3
11. Russo G, Isobe M, Gatti R, et al. Molecular analysis of a t(14; 14) translocation in leukemic T-cells of an ataxia telangiectasia patient. Proc Natl Acad Sci U S A 1989; 86: 602-6
12. Virgilio L, Isobe M, Narducci MG, et al. Chromosome walking on the tcl-1 locus involved in T-cell neoplasia. Proc Natl Acad Sci U S A 1993; 90: 9275-9
13. Virgilio L, Narducci M, Isobe M, et al. Identification of the TCL-1 gene involved in T cell malignancies. Proc Natl Acad Sci U S A 1994; 91: 12530-4
14. Pekarsky Y, Hallas C, Isobe M, et al. Abnormalities at 14q32.1 in T cell malignancies involve two oncogenes. Proc Natl Acad Sci U S A 1999; 96: 2949-51
15. Sugimoto J, Hatakeyama T, Narducci MG, et al. Identification of the TCL1/ MTCP1-like 1 (TML1) gene from the region next to the TCL1 locus. Cancer Res 1999; 59: 2313-7
16. Hallas C, Pekarsky Y, Itoyama T, et al. Genomic analysis of human and mouse TCL1 loci reveals a complex of tightly clustered genes. Proc Natl Acad Sci U S A 1999; 96: 14418-23
17. Saitou M, Sugimoto J, Hatakeyama T, et al. Identification of the TCL6 genes within the breakpoint cluster region on chromosome 14q32 in T-cell leukemia. Oncogene 2000; 19: 2796-802
18. Fu TB, Virgilio L, Narducci MG, et al. Characterization and localization of the TCL-1 oncogene product. Cancer Res 1994; 54: 6297-301
19. Stern MH, Soulier J, Rosenzwajg M, et al. MTCP-1: a novel gene on the human chromosome Xq28 translocated to the T cell receptor alpha/delta locus in mature T cell proliferation. Oncogene 1993; 8: 2475-80
20. Madani A, Choukroun V, Soulier J, et al. Expression of p13MTCP1 is restricted to mature T-cell proliferations with t(X; 14) translocations. Blood 1996; 87: 1923-7
21. Takizawa J, Suzuki R, Kuroda H, et al. Expression of the TCL1 gene at 14q32 in B-cell malignancies but not in adult T-cell leukemia. Jpn J Cancer Res 1998; 89: 712-8
22. Narducci MG, Pescarmona E, Lazzeri C, et al. Regulation of TCL1 expression in B- and T-cell lymphomas and reactive lymphoid tissues. Cancer Res 2000; 60: 2095-100
23. Said JW, Hoyer KK, French SW, et al. TCL1 oncogene expression in B cell subsets from lymphoid hyperplasia and distinct classes of B cell lymphoma. Lab Invest 2001; 81 (4): 555-64
24. Teitell M, Damore MA, Sulur GG, et al. TCL1 oncogene expression in AIDS-related lymphomas and lymphoid tissues. Proc Natl Acad Sci U S A 1999; 96: 9809-14
25. Taylor AMR, Metcalfe JA, et al. Leukemia and lymphoma in ataxia telangiectasia. Blood 1996; 87: 423-38
26. Thick J, Metcalfe JA, Mak YF, et al. Expression of either the TCL1 oncogene, or transcripts from its homologue MTCP1/c6.1B, in leukaemic and non-leukaemic T cells from ataxia telangiectasia patients. Oncogene 1996; 12: 379-86
27. Narducci MG, Virgilio L, Isobe M, et al. TCL1 oncogene activation in preleukemic T-cells from a case of ataxia telangiectasia. Blood 1995; 86: 2358-62
28. Narducci MG, Stoppacciaro A, Imada K, et al. TCL1 is overexpressed in patients affected by adult T-cell leukemias. Cancer Res 1997; 57: 5452-6
29. Ariyama Y, Mori T, Shinomiya T, et al. Chromosomal imbalances in adult T-cell leukemia revealed by comparative genomic hybridization: gains at 14q32 and 2p16-22 in cell lines. J Hum Genet 1999; 44: 357-63
30. Sakashita K, Kobayashi H, Satake N, et al. Amplification of the TCL1 flanking region at 14q32.1 with no TCL1 gene transcription in a patient with peripheral T cell lymphoma. Leukemia 1998; 12: 970-1
31. Kuppers R, Rajewsky K, Hansmann ML. Diffuse large cell lymphomas are derived from mature B cells carrying V region genes with a high load of somatic mutation and evidence of selection for antibody expression. Eur J Immunol 1997; 27: 1398-405
32. Virgilio L, Lazzeri C, Bichi R, et al. Deregulated expression of TCL1 causes T cell leukemia in mice. Proc Natl Acad Sci U S A 1998; 95: 3885-9
33. Gritti C, Dastot H, Soulier J, et al. Transgenic mice for MTCPI develop T-cell prolymphocytic leukemia. Blood 1998; 92: 368-73
34. Staal SP, Hartley JW, Rowe WP. Isolation of transforming murine leukemia viruses from mice with a high incidence of spontaneous lymphoma. Proc Natl Acad Sci U S A 1997; 74: 3065-7
35. Chan TO, Rittenhouse SE, Tsichlis PN. AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide-dependent phosphorylation. Annu Rev Biochem 1999; 68: 965-1014
36. Genot EM, Arrieumerlou C, Ku G, et al. The T-cell receptor regulates Akt (protein kinase B) via a pathway involving Rac1 and phosphatidylinositide 3-kinase. Mol Cell Biol 2000; 20: 5469-78
37. Brunet A, Bonni A, Zigmond MJ, et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 1999; 96: 857-68
38. Mok CL, Gil-Gomez G, Williams O, et al. Bad can act as a key regulator of T cell apoptosis and T cell development. J Exp Med 1999; 189: 575-86
39. Zimmermann S, Moelling K. Phosphorylation and regulation of Raf by Akt (protein kinase B). Science 1999; 286: 1741-4
40. Cross DA, Alessi DR, Cohen P, et al. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 1995; 378: 785-9
41. Du K, Montminy M, CREB is a regulatory target for the protein kinase Akt/PKB. J Biol Chem 1998; 273: 32377-9
42. Ozes ON, Mayo LD, Gustin JA, et al. NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 1999; 401: 82-5
43. Ahmed NN, Grimes HL, Bellacosa A, et al. Transduction of interleukin-2 antiapoptotic and proliferative signals via Akt protein kinase. Proc Natl Acad Sci U S A 1997; 94: 3627-32
44. Laine J, Kunstle G, Obata T, et al. The protooncogene TCL1 is an Akt kinase coactivator. Mol Cell 2000; 6: 395-407
45. Pekarsky Y, Koval A, Hallas C, et al. Tcl1 enhances Akt kinase activity and mediates its nuclear translocation. Proc Natl Acad Sci U S A 2000; 97: 3028-33
46. Kunstle G, Laine J, Pierron G, et al. Identification of Akt association and oligomerization domains of the Akt kinase coactivator TCL1. Mol Cell Biol 2002; 22: 1513-25
47. French SW, Shen RR, Koh PJ, et al. A modeled hydrophobic domain on the TCL1 oncoprotein mediates association with AKT at the cytoplasmic membrane. Biochemistry 2002; 41: 6376-82
48. Ahmed NN, Franke TF, Bellacosa A, et al. The proteins encoded by c-akt and v-akt differ in post-translational modification, subcellular localization and oncogenic potential. Oncogene 1993; 8: 1957-63
49. Laine J, Kunstle G, Obata T, et al. Differential regulation of Akt kinase isoforms by the members of the TCL1 oncogene family. J Biol Chem 2002; 277: 3743-51
50. Pekarsky Y, Hallas C, Palamarchuk A, et al. Akt phosphorylates and regulates the orphan nuclear receptor Nur77. Proc Natl Acad Sci U S A 2001; 98: 3690-4
51. Liu ZG, Smith SW, McLaughlin KA, et al. Apoptotic signals delivered through the T-cell receptor of a T-cell hybrid require the immediate-early gene nur77. Nature 1994; 367: 281-4
52. Xue Y, Chomez P, Castanos-Velez E, et al. Positive and negative thymic selection in T cell receptor-transgenic mice correlate with Nur77 mRNA expression. Eur J Immunol 1997; 27: 2048-56
53. Kuang AA, Cado D, Winoto A. Nur77 transcription activity correlates with its apoptotic function in vivo. Eur J Immunol 1999; 29: 3722-8
54. Davis IJ, Hazel TG, Chen R-H, et al. Functional domains and phosphorylation of the orphan receptor Nur77. Mol Endocrinol 1993; 7: 953-64
55. Masuyama N, Oishi K, Mori Y, et al. Akt inhibits the orphan nuclear receptor Nur77 and T-cell apoptosis. J Biol Chem 2001; 276: 32799-805